{"id":11382,"date":"2022-07-01T20:35:02","date_gmt":"2022-07-02T00:35:02","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/patient-to-patient-what-you-need-to-know-about-cancer-immunotherapy\/"},"modified":"2023-01-25T14:08:18","modified_gmt":"2023-01-25T19:08:18","slug":"immunotherapy-patient-perspectives","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/immunotherapy-patient-perspectives","title":{"rendered":"Patient to Patient: What You Need to Know About Cancer Immunotherapy"},"content":{"rendered":"\n<p class=\"has-text-align-center\"><iframe loading=\"lazy\" src=\"https:\/\/www.youtube.com\/embed\/y4-71OAJAqM\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n\n\n\n<p>How does a cancer diagnosis interrupt your life? Why choose immunotherapy? Two patients offer two very different perspectives on life with cancer, choosing a clinical trial, and figuring out what&#8217;s next in life.&nbsp;<\/p>\n\n\n\n<p>In this webinar designed for patients and caregivers, T.J. Sharpe and Donna Fernandez share their experiences with cancer immunotherapy and advice for patients currently seeking or receiving immunotherapy treatment.<\/p>\n\n\n\n<figure class=\"wp-block-image alignleft size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/TJ-headshot-webinar_300.png\" alt=\"TJ Sharpe Headshot\" class=\"wp-image-9558\" srcset=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/TJ-headshot-webinar_300.png 300w, https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/TJ-headshot-webinar_300-150x150.png 150w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/figure>\n\n\n\n<p><strong>T.J. Sharpe\u00a0<\/strong>was diagnosed with metastatic melanoma in 2012, just weeks after the birth of his second child. Not satisfied with the standard of care treatments offered to him, he and his family began exploring immunotherapy. Two clinical trials later, he is living a full life, now on maintenance Keytruda, devoting the bulk of his time to his family and to melanoma advocacy. T.J. writes a blog for\u00a0philly.com\u00a0called\u00a0Patient 1. (The name of his blog was inspired by the first clinical trial he enrolled in at Moffit Cancer Center, in which he was the first patient ever to receive Yervoy and TIL (tumor-infiltrating lymphocytes, a type of adoptive cell transfer).)<\/p>\n\n\n\n<figure class=\"wp-block-image alignleft size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/Donna-headshot-for-webinar_300.png\" alt=\"Donna Fernandez headshot\" class=\"wp-image-9404\" srcset=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/Donna-headshot-for-webinar_300.png 300w, https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/Donna-headshot-for-webinar_300-150x150.png 150w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/figure>\n\n\n\n<p><strong style=\"font-size: revert;\">Donna Fernandez<\/strong><span style=\"font-size: revert;\"> was first diagnosed with stage 4 lung cancer in 2012, when she went to the doctor believing she had a thyroid problem. At the time, Donna was working full time and doing dog agility several nights a week and every weekend. Her tumors did not respond to chemotherapy, and when faced with beginning a second chemotherapy regimen, Donna instead enrolled in an immunotherapy trial of nivolumab (Opdivo). Donna responded immediately. Her scans show that the tumors have remained stable. Donna continues training with her two dogs, Cotton and Barney. She says, \u201cOpdivo has let me live my life exactly how I want to. People talk about a \u201cnew normal\u201d after cancer, but I don\u2019t have a new normal. I\u2019m still living my old normal.\u201d<\/span><strong><a href=\"https:\/\/www.cancerresearch.org\/connect-with-immunoadvocates\/featured-stories\/donna-f\" target=\"_blank\" rel=\"noopener\"><\/a><\/strong><\/p>\n\n\n\n<p>The \u00abCancer Immunotherapy and You\u00bb webinar series is produced by the Cancer Research Institute and is made possible with generous support from Bristol-Myers Squibb, with additional support from Regeneron, Sanofi Genzyme, and Adaptimmune.<\/p>\n\n\n\n<p>Browse our <a href=\"https:\/\/www.youtube.com\/playlist?list=PLiGDIj2dVt-iOiV34MnZIkTiVF3iFgF_o\" target=\"_blank\" rel=\"noopener\">Cancer Immunotherapy and You Webinar Series playlist<\/a> on YouTube or visit the <a href=\"\/events\/webinars\">Webinars page<\/a> on our website to see other webinars in this series.<\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"600\" height=\"287\" src=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/Webinar_Sponsors_website_2018-calendar-year.png\" alt=\"2018 Cancer Immunotherapy and You Webinar Series Sponsors Bristol-Myers Squibb, Sanofi Genzyme, Regeneron, Adaptimmune\" class=\"wp-image-6614\" srcset=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/Webinar_Sponsors_website_2018-calendar-year.png 600w, https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/Webinar_Sponsors_website_2018-calendar-year-300x144.png 300w\" sizes=\"auto, (max-width: 600px) 100vw, 600px\" \/><\/figure>\n\n\n\n<p class=\"has-text-align-center\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cancer patients T.J. Sharpe and Donna Fernandez share their experiences with&nbsp;immunotherapy and advice for patients currently seeking or receiving immunotherapy treatment.<\/p>\n","protected":false},"featured_media":46,"template":"","events_categories":[198],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11382","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-webinars"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Webinar: Immunotherapy Patient Perspectives<\/title>\n<meta name=\"description\" content=\"Cancer patients T.J. Sharpe and Donna Fernandez share their experiences with\u00a0immunotherapy and advice for patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Webinar: Immunotherapy Patient Perspectives\" \/>\n<meta property=\"og:description\" content=\"Cancer patients T.J. Sharpe and Donna Fernandez share their experiences with\u00a0immunotherapy and advice for patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-25T19:08:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/1b638ecb-8f32-4187-b3de-2026730e0f1d.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Webinar: Immunotherapy Patient Perspectives\" \/>\n<meta name=\"twitter:description\" content=\"Cancer patients T.J. Sharpe and Donna Fernandez share their experiences with\u00a0immunotherapy and advice for patients.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/1b638ecb-8f32-4187-b3de-2026730e0f1d.png\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives\",\"name\":\"Webinar: Immunotherapy Patient Perspectives\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0ad29209-3bb0-470a-8ecf-28710f6d5383.png\",\"datePublished\":\"2022-07-02T00:35:02+00:00\",\"dateModified\":\"2023-01-25T19:08:18+00:00\",\"description\":\"Cancer patients T.J. Sharpe and Donna Fernandez share their experiences with\u00a0immunotherapy and advice for patients.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0ad29209-3bb0-470a-8ecf-28710f6d5383.png\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0ad29209-3bb0-470a-8ecf-28710f6d5383.png\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Patient to Patient: What You Need to Know About Cancer Immunotherapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Webinar: Immunotherapy Patient Perspectives","description":"Cancer patients T.J. Sharpe and Donna Fernandez share their experiences with\u00a0immunotherapy and advice for patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives","og_locale":"es_ES","og_type":"article","og_title":"Webinar: Immunotherapy Patient Perspectives","og_description":"Cancer patients T.J. Sharpe and Donna Fernandez share their experiences with\u00a0immunotherapy and advice for patients.","og_url":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives","og_site_name":"Cancer Research Institute","article_modified_time":"2023-01-25T19:08:18+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/1b638ecb-8f32-4187-b3de-2026730e0f1d.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"Webinar: Immunotherapy Patient Perspectives","twitter_description":"Cancer patients T.J. Sharpe and Donna Fernandez share their experiences with\u00a0immunotherapy and advice for patients.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/1b638ecb-8f32-4187-b3de-2026730e0f1d.png","twitter_misc":{"Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives","url":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives","name":"Webinar: Immunotherapy Patient Perspectives","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0ad29209-3bb0-470a-8ecf-28710f6d5383.png","datePublished":"2022-07-02T00:35:02+00:00","dateModified":"2023-01-25T19:08:18+00:00","description":"Cancer patients T.J. Sharpe and Donna Fernandez share their experiences with\u00a0immunotherapy and advice for patients.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0ad29209-3bb0-470a-8ecf-28710f6d5383.png","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0ad29209-3bb0-470a-8ecf-28710f6d5383.png","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-patient-perspectives#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"Patient to Patient: What You Need to Know About Cancer Immunotherapy"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11382","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/46"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11382"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11382"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11382"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11382"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11382"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11382"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11382"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}